MYCN promotes neuroblastoma malignancy by establishing a regulatory circuit with transcription factor AP4

Amplification of the MYCN oncogene, a member of the MYC family of transcriptional regulators, is one of the most powerful prognostic markers identified for poor outcome in neuroblastoma, the most common extracranial solid cancer in childhood. While MYCN has been established as a key driver of malign...

Descripción completa

Detalles Bibliográficos
Autores principales: Xue, Chengyuan, Yu, Denise M.T., Gherardi, Samuele, Koach, Jessica, Milazzo, Giorgio, Gamble, Laura, Liu, Bing, Valli, Emanuele, Russell, Amanda J., London, Wendy B., Liu, Tao, Cheung, Belamy B., Marshall, Glenn M., Perini, Giovanni, Haber, Michelle, Norris, Murray D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5342392/
https://www.ncbi.nlm.nih.gov/pubmed/27448979
http://dx.doi.org/10.18632/oncotarget.10709

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5342392/
https://www.ncbi.nlm.nih.gov/pubmed/27448979
http://dx.doi.org/10.18632/oncotarget.10709

Ejemplares similares